OA-29 First Results from the Randomized Portion of a Phase 2 Study of Venetoclax Plus Carfilzomib-Dexamethasone Vs Carfilzomib-Dexamethasone in Patients with T(11;14) Relapsed/refractory Multiple Myeloma
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
Key words
International Myeloma Working Group
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined